While CAR T-cell therapy shows promise, challenges remain. These include toxic effects on healthy cells, limited effectiveness against certain tumors, tumor mutation, and difficulty reaching and infiltrating solid tumors. So, how can we develop more successful CAR T therapies?

Download the factsheet for your queries and discover how Reaction Biology’s platform tackles these limitations.